Literature DB >> 23649050

Comparison of the roles of serratiopeptidase and dexamethasone in the control of inflammation and trismus following impacted third molar surgery.

K Murugesan1, K Sreekumar, B Sabapathy.   

Abstract

INTRODUCTION: Surgical extraction of lower 3 rd molar is the most frequent intervention in oral surgery. This procedure is often associated with significant post operative swelling that may have both biological and social implications. Various studies have been done using different anti inflammatory drugs to study their impact on inflammation.
MATERIAL AND METHODS: This study was conducted on 110 patients who had undergone surgical removal of mandibular third molar. The subjects were divided into two groups by double blind method. In addition to post operative swelling and pain , trismus was evaluated using two different groups of drugs.
RESULTS: One group was administered 1 mg of dexamethazone every 8 hours for 3 days post operatively. The other group was administered 10 mg of serratiopaptidase every 8 hours for 3 days post operatively. Swelling, pain and trismus were assessed on the 1 st , 3 rd , 5 th and 7 th post operative days. The results of the studies were statistically analysed.
CONCLUSION: The results showed dexamethazone was more effective in reduction of swelling and pain in comparison with serratiopaptidase. Both dexamethazone and serratiopaptidase had the same effect on trismus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23649050     DOI: 10.4103/0970-9290.111243

Source DB:  PubMed          Journal:  Indian J Dent Res        ISSN: 0970-9290


  5 in total

Review 1.  Role of Serratiopeptidase After Surgical Removal of Impacted Molar: A Systematic Review and Meta-analysis.

Authors:  Gowri Sivaramakrishnan; Kannan Sridharan
Journal:  J Maxillofac Oral Surg       Date:  2017-01-18

2.  Comparison of clinical efficacy of methylprednisolone and serratiopeptidase for reduction of postoperative sequelae after lower third molar surgery.

Authors:  Mouneshkumar Chappi D; Kandagal V Suresh; Manisha R Patil; Rajendra Desai; David P Tauro; Shiva Bharani K N S; Mushtaq I Parkar; Harsha V Babaji
Journal:  J Clin Exp Dent       Date:  2015-04-01

3.  Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trial.

Authors:  Zaid Tamimi; Rola Al Habashneh; Islam Hamad; Mutasim Al-Ghazawi; Ala' Abu Roqa'a; Hamza Kharashgeh
Journal:  BMC Oral Health       Date:  2021-03-02       Impact factor: 2.757

4.  Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.

Authors:  Charu Sharma; Niraj Kumar Jha; M F Nagoor Meeran; Chandragouda R Patil; Sameer N Goyal; Shreesh Ojha
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

5.  Efficacy of Submucosal Injection of Chymotrypsin, Oral Serratiopeptidase or Oral Dexamethasone in Reducing Postoperative Complications Following Impacted Lower Third Molar Surgery: A Prospective, Randomized, Double-Blind, Controlled Clinical Trial.

Authors:  Essam Ahmed Al-Moraissi; Elham Aziz Al-Zendani; Abeer Mohammed Al-Selwi
Journal:  Front Oral Health       Date:  2020-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.